TRACEY CASTELLA: Open Payments
NPI 1346752094 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 30 payments from 12 companies in 2025. Trend: 2023 $180 · 2024 $750 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $183 |
| W. L. Gore & Associates, Inc. | 1 | $122 |
| SK Life Science, Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| Boston Scientific Corporation | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Neurelis, Inc. | 1 | $16 |
Products named: GORE CARDIOFORM Septal Occluder, BOTOX, UBRELVY, KESIMPTA, QULIPTA, General - DBS, INGREZZA, Leqembi.
Industry payments across NJ — which companies pay providers there.
